You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 897-C TROCEPT tumor-specific targeting and replication enables in-tumor production of immune checkpoint inhibitors following intravenous delivery

Article metrics

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Combination Immunotherapies
897-C TROCEPT tumor-specific targeting and replication enables in-tumor production of immune checkpoint inhibitors following intravenous delivery

 

Online download statistics by month:

Online download statistics by month: December 2023 to June 2025

AbstractFullPdf
Dec 20232602
Jan 20243603
Feb 20245407
Mar 202440029
Apr 20245406
May 20244602
Jun 20241402
Jul 20241802
Aug 20241205
Sep 20241602
Oct 20242207
Nov 20242808
Dec 20241607
Jan 202528010
Feb 2025605
Mar 2025008
Apr 2025104
May 2025005
Jun 2025009
Total4170123